LeMaitre Q3 sales $38.4M (+5% organic), EPS $0.30 (-19%), declares $0.11 dividend

LEMAITRE VASCULAR INC

2021-Q3 EPS reported $0.98 revenue$114,921,000

Net income $6.5M (-13%), op. income $9.1M (-9%), gross margin 64.8% (+250 bps).
Cash & investments $67.1M after $58.7M stock offering; Artegraft debt paid off.
Q4 guidance: sales $39–41M (midpoint +7%), EPS $0.29–0.34 (-8% midpoint).
Quarterly dividend $0.11/share, payable Dec 2 to holders of record Nov 19.
Americas and EMEA grew 5% each, APAC up 16%; Delta variant deferred elective surgeries.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.